Home » Topics » BioWorld Science

BioWorld Science
RSS

Inhibitors of the production or release of sCD23, TNF

Jan. 29, 1998

Dopamine D4 receptor antagonists for imaging and therapy disclosed by Janssen

Jan. 29, 1998

Clinical development of LM-AS-013 advances at Green Cross

Jan. 29, 1998

Company Profile: Millennium

Jan. 29, 1998

ACT evaluated in second phase I trial in HIV/AIDS patients

Jan. 28, 1998

Viragen seeks to become fully integrated blood products company

Jan. 28, 1998

Vaccine delivery joint venture finalized by Endorex and Elan

Jan. 28, 1998

Japanese approval for Biora's periodontal disease product

Jan. 28, 1998

Pacific's cancer immunotherapy proves highly effective in rat metastatic mammary tumor model

Jan. 28, 1998

Phase II trials of Sibia's Parkinson's disease Rx begin

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...